Which formal channels can you buy Elacetrant in the country and what are your purchasing suggestions?

Elacestrant (Elacestrant) is not yet officially launched in China, so patients cannot purchase it directly through domestic hospitals or pharmacies. As a new oral selective estrogen receptor degrader (SERD), it is mainly used to treat patients with hormone receptor-positive, HER2-negative advanced breast cancer. Although the drug has been sold in the international market, if domestic patients need to use it, they must obtain it through formal overseas channels and must follow strict import regulations and medical supervision.

In the overseas market, the original drug of elastran mainly has a European version, which costs about more than 30,000 yuan per box, which is relatively expensive. For some patients, the financial burden is relatively high, so some patients may choose overseas generic drugs, such as the Lao version of generic drugs, which cost about more than 2,000 yuan. Although the price is lower, when purchasing, you need to confirm that the source of the drug is legal, that the drug ingredients are consistent with the original drug, and that the drug is imported through formal channels to ensure safety and efficacy.

When purchasing elastran, it is recommended that patients consult and purchase through international medical institutions, overseas pharmacies or overseas medical service platforms, and avoid obtaining drugs through informal channels to prevent counterfeit or inferior drugs from affecting the treatment effect. At the same time, patients should fully understand the usage, dosage and potential adverse reactions of the drug before use, and take it under the guidance of a professional doctor to ensure the safety of treatment.

Generally speaking, there are currently no formal channels for purchasing elastran in China, and overseas imports are the only option. When considering use, patients should consider drug cost, legality and medical safety, and give priority to legal and credible channels. At the same time, patients should cooperate with doctors for regular follow-up and efficacy evaluation to ensure the safety and effectiveness of drug use and achieve the best clinical treatment effect.

Reference materials:https://www.drugs.com/